Latini R - Search Results

1

Heart 'omics' in AGEing (HOMAGE): design, research objectives and characteristics of the common database.

Jacobs L, Thijs L, Jin Y, Zannad F, Mebazaa A, Rouet P, Pinet F, Bauters C, Pieske B, Tomaschitz A, Mamas M, Diez J, McDonald K, Cleland JG, Brunner-La Rocca HP, Heymans S, Latini R, Masson S, Sever P, Delles C, Pocock S, Collier T, Kuznetsova T, Staessen JA. Jacobs L, et al. Among authors: latini r. J Biomed Res. 2014 Sep;28(5):349-59. doi: 10.7555/JBR.28.20140045. Epub 2014 Jul 31. J Biomed Res. 2014. PMID: 25332706 Free PMC article.

2

Comparative measurement of N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in ambulatory patients with heart failure.

Masson S, Vago T, Baldi G, Salio M, De Angelis N, Nicolis E, Maggioni AP, Latini R, Norbiato G, Bevilacqua M. Masson S, et al. Among authors: latini r. Clin Chem Lab Med. 2002 Aug;40(8):761-3. doi: 10.1515/CCLM.2002.130. Clin Chem Lab Med. 2002. PMID: 12392300

3

[Refractory heart failure. Antagonism of tumor necrosis factor alpha and endothelin in humans: 2 promises still to be honored].

Valgimigli M, Ferrari R, Masson S, Latini R. Valgimigli M, et al. Among authors: latini r. Ital Heart J Suppl. 2002 Aug;3(8):793-803. Ital Heart J Suppl. 2002. PMID: 12407834 Review. Italian.

4

Role of brain natriuretic peptide in the diagnosis and management of heart failure: current concepts.

Latini R, Masson S, de Angelis N, Anand I. Latini R, et al. J Card Fail. 2002 Oct;8(5):288-99. doi: 10.1054/jcaf.2002.0805288. J Card Fail. 2002. PMID: 12411979 Review.

5

Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT).

Latini R, Masson S, Anand I, Judd D, Maggioni AP, Chiang YT, Bevilacqua M, Salio M, Cardano P, Dunselman PH, Holwerda NJ, Tognoni G, Cohn JN; Valsartan Heart Failure Trial Investigators. Latini R, et al. Circulation. 2002 Nov 5;106(19):2454-8. doi: 10.1161/01.cir.0000036747.68104.ac. Circulation. 2002. PMID: 12417542 Clinical Trial.

6

Appraisal of the role of angiotensin II and aldosterone in ventricular myocyte apoptosis in adult normotensive rat.

De Angelis N, Fiordaliso F, Latini R, Calvillo L, Funicello M, Gobbi M, Mennini T, Masson S. De Angelis N, et al. Among authors: latini r. J Mol Cell Cardiol. 2002 Dec;34(12):1655-65. doi: 10.1006/jmcc.2002.2115. J Mol Cell Cardiol. 2002. PMID: 12505063

7

In vivo cardioprotection by N-acetylcysteine and isosorbide 5-mononitrate in a rat model of ischemia-reperfusion.

Calvillo L, Masson S, Salio M, Pollicino L, De Angelis N, Fiordaliso F, Bai A, Ghezzi P, Santangelo F, Latini R. Calvillo L, et al. Among authors: latini r. Cardiovasc Drugs Ther. 2003 May;17(3):199-208. doi: 10.1023/a:1026182404805. Cardiovasc Drugs Ther. 2003. PMID: 14574078

8

Valsartan for the treatment of heart failure.

Latini R, Masson S, Staszewsky L, Maggioni AP. Latini R, et al. Expert Opin Pharmacother. 2004 Jan;5(1):181-93. doi: 10.1517/14656566.5.1.181. Expert Opin Pharmacother. 2004. PMID: 14680446 Review.

9

The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT.

Latini R, Masson S, Anand I, Salio M, Hester A, Judd D, Barlera S, Maggioni AP, Tognoni G, Cohn JN; Val-HeFT Investigators. Latini R, et al. Eur Heart J. 2004 Feb;25(4):292-9. doi: 10.1016/j.ehj.2003.10.030. Eur Heart J. 2004. PMID: 14984917 Clinical Trial.

10

Myocardial infarction: animal models.

Chimenti S, Carlo E, Masson S, Bai A, Latini R. Chimenti S, et al. Among authors: latini r. Methods Mol Med. 2004;98:217-26. doi: 10.1385/1-59259-771-8:217. Methods Mol Med. 2004. PMID: 15064443

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

527 results

Search Page